Biography/Memoir

Psilocybin is headed for the mainstream… it’s bringing the problems of Big Pharma with it

“That’s the case with the pharmaceutical industry time and time again: good intentions are marred by the drive to maximize revenue.” -Adam Winstock, MD (University College London, an addiction medicine specialist and founder of the Global Drug Survey.)

While psilocybin is a naturally occurring molecule, the chemistry to develop a standardized synthetic version deemed safe by medical authorities is complex… patenting its chemical process and therapeutic model, this is standard practice for pharmaceutical companies. “It is troubling that substances that have traditionally been linked with healing and spiritual growth are at risk of becoming monetized as commodities,” says Bruce Tobin, director of TheraPsil, a group of Canadian physicians working to make psilocybin legal for treating severe psychological distress. “Those of us in the ‘old vanguard’ have been motivated by the prospect of advancing the human condition. Profit for individuals at the expense of the public interest is anathema to us.” … “Companies investing in psychedelics, of course, will be motivated by a desire to improve the human condition, but they will also be motivated by profit, which invariably will skew things,” says Adam Winstock, MD, of University College London, an addiction medicine specialist and founder of the Global Drug Survey. “That’s the case with the pharmaceutical industry time and time again: good intentions are marred by the drive to maximize revenue.”

Original Article (Elemental Medium):
Psilocybin is headed for the mainstream… it’s bringing the problems of Big Pharma with it
Artwork Fair Use: Vegas B.

Sound off : on Kratom

…overdoses spike climbs to 23

…shares his story…